Nitinol Medical Devices Market Size is Predicted to Expand at a CAGR of 8.5% to Reach US$ 30,037.9 Million by 2027| Report Transparency Market Research

𝐍𝐢𝐭𝐢𝐧𝐨𝐥 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 was valued at US$ 14,571.7 Mn in 2018 and to reach US$ 30,037.9 Mn by 2027, it is anticipated to expand at a CAGR of 8.5% from 2019 to 2027.

𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

Rise in prevalence of cardiovascular diseases is likely to increase the number of cardiovascular surgical procedures globally. Hence, demand for nitinol-based medical devices such as stents, catheters, and guidewires is projected to increase due to quick and safe surgical procedures.

According to World Health Organization statistics (2017), cardiovascular diseases affect 17.7 million people each year. Approximately 31% of global death occurs due to cardiovascular diseases.

According to white paper published by HCL "Design Engineering of Nitinol based Medical Devices", recent growth in the cardiovascular industry indicates a significant market potential in the medical devices segment. Superelastic nature of the metal increases extensive usage in medical products such as stent and guide wire. In the past few years, inferior vena cava filters and embolic protection devices have witnessed significant commercial success.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1685&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬:

Arthrex, Inc.,Boston Scientific Corporation,C. R. Bard, Inc.,Cook Medical, Inc.,ENDOSMART GmbH,Medtronic plc,B. Braun Melsungen AG,W. L. Gore & Associates, Inc.,Terumo Medical Corporation, Abbott Laboratories.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Nitinol Stents
Nitinol Guidewires
Orthodontic Guidewires
Endoscopic Guidewires
Nitinol Filters
Nitinol Basket
Nitinol Catheters
Others

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Orthopedic
Vascular
Dental
Gastroenterology
Others

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In January 2017, Abbott Laboratories acquired St. Jude Medical (SJM). The acquisition of St. Jude Medical will advance the company's revenue growth is cardiovascular care and neuromodulation devices. The company is also focusing on developing new designs for Supera self expanding nitinol stent system used in the treatment of peripheral artery disease.

In October 2016, Medtronic's CoreValve Evolut R 34 mm valve received the U.S. Food and Drug Administration (FDA) approval. The system delivers a greater opportunity to treat patients with smaller vessels through the preferred transfemoral access route.

In August 2016, W.L. Gore and Associates, Inc. announced the U.S. Food and Drug Administration (FDA) approval for the GORE TIGRIS Vascular Stent, a dual-component stent with a unique fluoropolymer/nitinol design. This will improve anatomical conformability with the natural movement of the knee when treating peripheral artery disease (PAD)

In December 2015, Boston Scientific Corporation acquired the interventional radiology portfolio of CeloNova Biosciences (CeloNova). The acquisition includes drug-eluting microspheres, which can be used for delivery of chemotherapy drugs to cancerous tumors and uterine fibroids.

In August 2015, Nitinol Devices & Components, Inc. (NDC) of Confluent Medical Technologies completed the acquisition of Interface Catheter Solutions. The acquisition of company create an unique opportunity to strengthen the relationships with the existing customer particularly in the endovascular, neurovascular market

𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐈𝐧𝐬𝐭𝐚𝐧𝐭𝐥𝐲:
https://www.transparencymarketresearch.com/checkout.php?rep_id=1685<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐑𝐞𝐠𝐢𝐨𝐧𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝:

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Emerging trends in the Nitinol medical devices market include the development of customized implants using 3D printing technology, the integration of Nitinol alloys with biocompatible materials, and the adoption of smart Nitinol devices with remote monitoring capabilities.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The Nitinol medical devices market is poised for continuous expansion, driven by ongoing research and development efforts, strategic collaborations between industry players, and the introduction of innovative products catering to diverse medical needs.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Key areas of focus for market study include analyzing the competitive landscape, assessing regulatory compliance, understanding consumer preferences, and evaluating emerging technologies shaping the Nitinol medical devices market.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐓𝐚𝐦𝐩𝐢𝐧𝐠 𝐌𝐚𝐜𝐡𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/15/2669421/0/en/Tamping-Machine-Market-is-Expected-to-See-a-Growth-of-5-4-From-2023-2031-Exclusive-Report-by-Transparency-Market-Research.html

𝐕𝐞𝐡𝐢𝐜𝐥𝐞 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭-https://www.globenewswire.com/news-release/2023/05/15/2669358/0/en/Global-Sales-of-Vehicle-Subscription-is-Expected-to-Accelerate-at-a-Whopping-21-1-CAGR-Reaching-US-33-2-Billion-by-2031-TMR-Report.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com        
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.